Home/Filings/4/0001209191-21-045513
4//SEC Filing

BASTA JAMES 4

Accession 0001209191-21-045513

CIK 0001652130other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:44 PM ET

Size

5.4 KB

Accession

0001209191-21-045513

Insider Transaction Report

Form 4
Period: 2021-07-01
BASTA JAMES
EVP, General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-07-01+130,000130,000 total
    Exercise: $171.65Exp: 2031-06-30Common Stock (130,000 underlying)
Footnotes (1)
  • [F1]This option was granted on July 1, 2021 with respect to 130,000 shares of Common Stock, with 25% vesting on July 1, 2022 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1
  • filerCIK 0001792726

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:44 PM ET
Size
5.4 KB